We are updating the BioProcess Containers (BPCs) used for our 10L pack sizes. Please refer to Cat. No. A4000311302 to purchase validation material in our new packaging.
Actual product may vary
Gibco™
CTS™ AIM V™ SFM
GIBCO™ CTS™ AIM V™ SFM(治疗级)是商业化的可用于 T 细胞和树突状细胞的增殖和/或控制的成分确定的无血清培养基 (SFM),生产过程符合了解更多信息
Will CTS AIM V SFM (Cat. No. 0870112BK) be discontinued?
No. CTS AIM V SFM (Cat. No. 0870112BK) will not be discontinued. The same catalog number will be available with the new Aegis5-14 film following the planned transition in 2026.
What is the difference between CTS AIM V SFM VALIDATION (Cat. No. A4000311302) and CTS AIM V SFM (Cat. No. 0870112BK)?
The two media have the same formulation and GMP quality and are manufactured in ISO13485, MDSAP, FDA-registered, 21 CFR820 facilities. The main difference lies in the packaging. CTS AIM V SFM VALIDATION (Cat. No. A4000311302) is packaged in the Aegis 5-14 BioProcessing Container (BPC) with a low-density polyethylene (LDPE) contact layer and updated tubing and connector options. On the other hand, the current CTS AIM V SFM (Cat. No. 0870112BK) is packaged in ASI 28 film with an ethylene vinyl acetate (EVA) contact layer and four spike ports.
The Gibco Cell Therapy Systems (CTS) portfolio of cell and gene therapy products are GMP manufactured, safety tested, and backed by regulatory documentation to support your transition from discovery through clinical and commercial manufacturing. Through our CTS solutions, we are committed to helping customers streamline therapeutic development, minimize risk, and ease the burden on their quality systems. Learn more here.